OpenParable
Skip to content
← Back to skills

Clinical Pharmacology Guide

Others
clinical-pharmacology-guide

Clinical Pharmacology Guide is an Agent Skill for general use published in the brycewang-stanford/Auto-Empirical-Research-Skills repository on GitHub: a SKILL.md instruction file an AI agent can load to do this task.

Clinical pharmacology principles for dosing, drug interactions, and patient s...

View on GitHub ↗
QUICK START

How to use this skill

Bring this guide into your coding agent with a prompt tailored to the tool you use.

  1. Open your project in Codex.
  2. Copy and paste the prompt below.
  3. Review files and risks before approving any action.
Prompt to paste
Inspect the Agent Skill at https://github.com/brycewang-stanford/Auto-Empirical-Research-Skills/blob/HEAD/skills/43-wentorai-research-plugins/skills/domains/pharma/clinical-pharmacology-guide/SKILL.md and all supporting files. Report provenance, permissions, scripts, dependencies, and security risks. Propose an exact installation into .agents/skills/clinical-pharmacology-guide, but wait for my approval before writing files or running scripts.

Copying this prompt does not install or run the skill. Review third-party files before use.

Clinical Pharmacology Guide

A skill for applying clinical pharmacology principles to research and practice. Covers pharmacokinetic/pharmacodynamic modeling, drug interaction assessment, therapeutic drug monitoring, and special population dosing.

Pharmacokinetic-Pharmacodynamic (PK/PD) Relationships

The Emax Model

The most widely used PK/PD model relates drug concentration to effect:

import numpy as np
import matplotlib.pyplot as plt

def emax_model(concentration: np.ndarray, emax: float, ec50: float,
                hill: float = 1, baseline: float = 0) -> np.ndarray:
    """
    Sigmoid Emax (Hill) model.

    Args:
        concentration: Drug concentration array
        emax: Maximum effect
        ec50: Concentration producing 50% of Emax
        hill: Hill coefficient (steepness)
        baseline: Baseline effect (E0)
    """
    effect = baseline + (emax * concentration**hill) / (ec50**hill + concentration**hill)
    return effect

# Example: dose-response curve
conc = np.logspace(-2, 3, 200)
effect = emax_model(conc, emax=100, ec50=10, hill=1.5)

fig, ax = plt.subplots(figsize=(8, 5))
ax.semilogx(conc, effect)
ax.set_xlabel('Concentration (ng/mL)')
ax.set_ylabel('Effect (%)')
ax.set_title('Sigmoid Emax Model')
ax.axhline(y=50, color='gray', linestyle='--', alpha=0.5)
ax.axvline(x=10, color='gray', linestyle='--', alpha=0.5)
ax.annotate('EC50', xy=(10, 50), fontsize=12)
plt.tight_layout()

Drug Interaction Assessment

Cytochrome P450 Interaction Prediction

def predict_cyp_interaction(victim_drug: dict, perpetrator_drug: dict) -> dict:
    """
    Predict metabolic drug-drug interaction potential.

    Args:
        victim_drug: {'name': str, 'primary_cyp': str, 'fraction_metabolized': float}
        perpetrator_drug: {'name': str, 'cyp_effects': dict}
            cyp_effects maps CYP enzyme to 'inhibitor'|'inducer'|'none'
    """
    cyp = victim_drug['primary_cyp']
    fm = victim_drug['fraction_metabolized']  # fraction metabolized by this CYP

    perp_effect = perpetrator_drug['cyp_effects'].get(cyp, 'none')

    if perp_effect == 'inhibitor':
        # AUC ratio = 1 / (1 - fm) for complete inhibition
        auc_ratio = 1 / (1 - fm) if fm < 1 else float('inf')
        risk = 'high' if auc_ratio > 5 else 'moderate' if auc_ratio > 2 else 'low'
    elif perp_effect == 'inducer':
        # Induction decreases exposure
        auc_ratio = 1 - fm * 0.7  # approximate 70% induction
        risk = 'high' if auc_ratio < 0.3 else 'moderate' if auc_ratio < 0.5 else 'low'
    else:
        auc_ratio = 1.0
        risk = 'none'

    return {
        'victim': victim_drug['name'],
        'perpetrator': perpetrator_drug['name'],
        'affected_cyp': cyp,
        'interaction_type': perp_effect,
        'predicted_auc_ratio': round(auc_ratio, 2),
        'clinical_risk': risk,
        'recommendation': (
            'Dose adjustment required' if risk == 'high'
            else 'Monitor closely' if risk == 'moderate'
            else 'No action needed'
        )
    }

Therapeutic Drug Monitoring (TDM)

Narrow Therapeutic Index Drugs

Drugs requiring routine TDM due to narrow therapeutic windows:

DrugTherapeutic RangeToxic LevelMonitoring Frequency
VancomycinAUC/MIC 400-600AUC/MIC > 600Trough before 4th dose
Lithium0.6-1.2 mEq/L> 1.5 mEq/LWeekly initially, then monthly
Digoxin0.8-2.0 ng/mL> 2.0 ng/mLAt steady state (5-7 days)
Phenytoin10-20 mcg/mL> 20 mcg/mL2 weeks after dose change
Tacrolimus5-15 ng/mL> 20 ng/mLTwice weekly post-transplant

Bayesian TDM

def bayesian_dose_adjustment(prior_cl: float, prior_cl_cv: float,
                              measured_conc: float, expected_conc: float,
                              current_dose: float) -> dict:
    """
    Simple Bayesian dose adjustment using one-point TDM.

    Args:
        prior_cl: Population clearance estimate (L/hr)
        prior_cl_cv: CV of clearance in population (0-1)
        measured_conc: Observed trough concentration
        expected_conc: Expected concentration at population CL
        current_dose: Current dose (mg)
    """
    # Individual clearance estimate (MAP approach, simplified)
    ratio = expected_conc / measured_conc
    individual_cl = prior_cl * ratio

    # Bayesian shrinkage toward population
    weight = 1 / (1 + prior_cl_cv**2)
    posterior_cl = weight * prior_cl + (1 - weight) * individual_cl

    # New dose to achieve target
    target_conc = (measured_conc + expected_conc) / 2  # midpoint of range
    new_dose = current_dose * (posterior_cl / prior_cl)

    return {
        'individual_CL': round(individual_cl, 2),
        'posterior_CL': round(posterior_cl, 2),
        'recommended_dose': round(new_dose, 1),
        'dose_change_pct': round((new_dose - current_dose) / current_dose * 100, 1)
    }

Special Populations

Dosing considerations for specific patient groups:

  • Renal impairment: Use Cockcroft-Gault or CKD-EPI for GFR estimation; adjust doses for renally cleared drugs proportionally
  • Hepatic impairment: Use Child-Pugh score; reduce doses of hepatically metabolized drugs by 25-50% for moderate impairment
  • Pediatric: Use allometric scaling (CL proportional to body weight^0.75) rather than simple mg/kg dosing
  • Geriatric: Account for decreased renal function, polypharmacy, and altered body composition
  • Pregnancy: Increased clearance for many drugs due to increased blood volume and GFR

Regulatory Considerations

All clinical pharmacology studies should follow ICH guidelines (E4 for dose-response, E5 for ethnic factors, E7 for geriatric, E11 for pediatric). Report results in standardized population PK/PD formats compatible with FDA and EMA submission requirements.